Eleanor Pullenayegum

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada

Feng Xie, Eleanor Pullenayegum, Kathy Gaebel et al. · Medical Care · 2015 · 485 citations · Full text

Pharmacy, Health Sciences, Health Assessment +16

United States Valuation of EQ-5D-5L Health States Using an International Protocol

A. Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health · 2019 · 391 citations · Full text

Pharmacy, Educational Measurement, Health Assessment +16

Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial

Eleanor Gurnell, Penelope J. Hunt, Suzanne Curran et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 188 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Potentiating Cancer Immunotherapy Using an Oncolytic Virus

Byram W. Bridle, Kyle B. Stephenson, Jeanette E. Boudreau et al. · Molecular Therapy · 2010 · 175 citations · Full text

Medicine, Immunology, Oncology +17

Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?

Eleanor Pullenayegum, Jean‐Éric Tarride, Feng Xie et al. · Value in Health · 2010 · 162 citations · Full text

Pharmacy, Pharmacoeconomics, Epidemiologic Methods +13